Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis.
about
Commentary on changing the risk threshold for surgical prevention of ovarian cancer.Moving towards population-based genetic risk prediction for ovarian cancer.Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development.A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancerEvaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort studyPopulation based germline testing for primary cancer prevention
P2860
Q39209405-A0137E84-258B-4F0A-A43E-5F273B7A68DAQ40327531-ACBD55E9-3947-4FE4-AF0A-ABAD6CEF98D7Q47110015-9092B8EC-4795-4584-9C88-9F0EFA5658A1Q49884536-C96CD6F8-C8F3-4BF6-827A-EA901221480AQ56527583-0A5583C5-1CA0-43CA-A921-EED558B41464Q57172770-8FAD17A0-4372-4D36-889D-7C4BAFC95095Q58764429-5B57CED7-AC0D-4F9D-A392-3345A2A30946
P2860
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Specifying the ovarian cancer ...... a cost-effectiveness analysis.
@en
Specifying the ovarian cancer ...... a cost-effectiveness analysis.
@nl
type
label
Specifying the ovarian cancer ...... a cost-effectiveness analysis.
@en
Specifying the ovarian cancer ...... a cost-effectiveness analysis.
@nl
prefLabel
Specifying the ovarian cancer ...... a cost-effectiveness analysis.
@en
Specifying the ovarian cancer ...... a cost-effectiveness analysis.
@nl
P50
P1476
Specifying the ovarian cancer ...... a cost-effectiveness analysis.
@en
P2093
Rosa Legood
P304
P356
10.1136/JMEDGENET-2016-103800
P407
P577
2016-06-27T00:00:00Z